Naltrexone, an FDA approved drug to ease symptoms of alcohol and drug addiction has been found in a Penn State College of Medicine pilot study to bring relief to people with Crohn’s disease.
Crohns’s disease is a chronic inflammatory disorder of the intestine whose typical treatment involves using steroids and corticosteroids – treatment regimens that suppresses the immune system including other toxic side effects, not to mention being intensive and expensive.
The results showed that 89 percent of participants showed an improvement with therapy, while 67 percent achieved remission of symptoms. The only side effect to treatment was sleep disturbance in some patients. "This is a novel approach to treating a common disease, and it's simple, it's safe, and it costs far less than current standards of treatment," Smith said. "We don't yet know the exact mechanisms involved in how it works, but we're working on that as well."Read more at EurekAlert.
» Naltrexone Decreases Urge to Gamble from PharmaGazette
A new study released by Dr. Jon E. Grant of the University of Minnesota in Minneapolis and his colleagues has found that the urge to gamble was decreased in pathological gamblers who were treated with naltrexone.Naltrexone, a drug frequently used... [Read More]
Tracked on: June 12, 2008 12:03 AM | Permalink to Trackback